EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combination therapy of itraconazole and an acylhydrazone derivative (D13) for the treatment of sporotrichosis in cats

Isabella Dib Ferreira Gremião iD, Gabriela Reis Pereira-Oliveira, Sandro Antonio Pereira, Maria Lopes Corrêa, Luana Pereira Borba-Santos, Alessandra Lifsitch Viçosa, Ashna Garg, Krupanandan Haranahalli, Deveney Dasilva, Nivea Pereira de Sa, Gabriel S Matos, Vanessa Silva und 10 weitere

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.03967-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Isabella Dib Ferreira Gremião und 21 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Research on Dermatozoonoses in Domestic Animals, Evandro Chagas National Institute of Infectious Diseases, Rio de Janeiro, Bra…. Hauptthemen laut MEDLINE: Itraconazole, Sporotrichosis, Antifungal Agents, Cat Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Defense (DOD), Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ), HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acylhydrazone (AH) derivatives represent a novel category of anti-fungal medications that exhibit potent activity against Sporothrix sp., both in vitro and in a murine model of sporotrichosis. In this study, we demonstrated the anti-fungal efficacy of the AH derivative D13 [4-bromo- N ′-(3,5-dibromo-2-hydroxybenzylidene)-benzohydrazide] against both planktonic cells and biofilms formed by Sporothrix brasiliensis . In a clinical study, the effect of D13 was then tested in combination with itraconazole (ITC), with or without potassium iodide, in 10 cats with sporotrichosis refractory to the treatment of standard of care with ITC. Improvement or total clinical cure was achieved in five cases after 12 weeks of treatment. Minimal abnormal laboratory findings, e.g., elevation of alanine aminotransferase, were observed in four cats during the combination treatment and returned to normal level within a week after the treatment was ended. Although highly encouraging, a larger and randomized controlled study is required to evaluate the effectiveness and the safety of this new and exciting drug combination using ITC and D13 for the treatment of feline sporotrichosis. IMPORTANCE This paper reports the first veterinary clinical study of an acylhydrazone anti-fungal (D13) combined with itraconazole against a dimorphic fungal infection, sporotrichosis, which is highly endemic in South America in animals and humans. Overall, the results show that the combination treatment was efficacious in ~50% of the infected animals. In addition, D13 was well tolerated during the course of the study. Thus, these results warrant the continuation of the research and development of this new class of anti-fungals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ItraconazoleSporotrichosisAntifungal AgentsCat DiseasesSporothrixDrug Therapy, CombinationCatsAnimalsHydrazonesFemaleMaleMicrobial Sensitivity TestsBiofilmsTreatment Outcome

Stichwörter der Autor:innen

Sporothrixacylhydrazoneanti-fungal therapycatsfungal infectionitraconazolesporotrichosisterbinafine

Substanzen

ItraconazoleAntifungal AgentsHydrazones

Autor:innen und Institutionen

  • Laboratory of Clinical Research on Dermatozoonoses in Domestic Animals, Evandro Chagas National Institute of Infectious Diseases, Rio de Janeiro, Brazil.
  • Laboratory of Fungal Cell Biology, Carlos Chagas Filho Institute of Biophysics, Rio de Janeiro, Brazil.
  • Laboratory of Experimental Pharmacotechnics, Institute of Drug Technology - Farmanguinhos, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
  • Institute of Chemical Biology and Drug Discovery, Stony Brook University, Stony Brook, New York, USA.
  • Department of Chemistry, Stony Brook University, Stony Brook, New York, USA.
  • Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, USA.

ORCID-Profile: Isabella Dib Ferreira Gremião, Jhon Jhamilton Artunduaga Bonilla, Maurizio Del Poeta

Förderung

  • U.S. Department of Defense (DOD)
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • NIAID NIH HHS
  • BLRD VA
  • U.S. Department of Veterans Affairs

Zitieren

APA

Dib Ferreira Gremião, I., Pereira-Oliveira, G. R., Pereira, S. A., Corrêa, M. L., Borba-Santos, L. P., Viçosa, A. L., Garg, A., Haranahalli, K., Dasilva, D., Pereira de Sa, N., Matos, G. S., Silva, V., Lazzarini, C., Fernandes, C. M., Miranda, K., Artunduaga Bonilla, J. J., Nunes, A. L., Nimrichter, L., Ojima, I., …, & Del Poeta, M. (2024). Combination therapy of itraconazole and an acylhydrazone derivative (D13) for the treatment of sporotrichosis in cats. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03967-23

Vancouver

Dib Ferreira Gremião I, Pereira-Oliveira GR, Pereira SA, Corrêa ML, Borba-Santos LP, Viçosa AL, et al. Combination therapy of itraconazole and an acylhydrazone derivative (D13) for the treatment of sporotrichosis in cats. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03967-23

BibTeX
@article{DibFerreiraGremio2024,
  author = {Dib Ferreira Gremião, Isabella and Pereira-Oliveira, Gabriela Reis and Pereira, Sandro Antonio and Corrêa, Maria Lopes and Borba-Santos, Luana Pereira and Viçosa, Alessandra Lifsitch and Garg, Ashna and Haranahalli, Krupanandan and Dasilva, Deveney and Pereira de Sa, Nivea and Matos, Gabriel S and Silva, Vanessa and Lazzarini, Cristina and Fernandes, Caroline Mota and Miranda, Kildare and Artunduaga Bonilla, Jhon Jhamilton and Nunes, Anna Letícia and Nimrichter, Leonardo and Ojima, Iwao and Mallamo, John and McCarthy, John B and Del Poeta, Maurizio},
  title = {Combination therapy of itraconazole and an acylhydrazone derivative (D13) for the treatment of sporotrichosis in cats},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.03967-23}
}
Kostenlos starten →